Canada Life
EXAS

Canada Life’s Exact Sciences EXAS Stock Holding History

Canada Life’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,341
Closed -$2.27M – 1853
2025
Q4 		$2.27M Sell
22,341
-37,065
-62% -$2.98M ﹤0.01% 1117
2025
Q3 		$3.17M Buy
59,406
+512
+0.9% +$25.6K ﹤0.01% 1026
2025
Q2 		$3.13M Sell
58,894
-23,359
-28% -$1.19M 0.01% 988
2025
Q1 		$3.57M Buy
82,253
+16,970
+26% +$859K 0.01% 930
2024
Q4 		$3.67M Buy
65,283
+80
+0.1% +$4.98K 0.01% 990
2024
Q3 		$4.45M Buy
65,203
+7,715
+13% +$435K 0.01% 935
2024
Q2 		$2.43M Sell
57,488
-149,876
-72% -$8.25M ﹤0.01% 1188
2024
Q1 		$14.4M Buy
207,364
+10,356
+5% +$655K 0.03% 478
2023
Q4 		$14.5M Buy
197,008
+142,809
+263% +$9.36M 0.03% 462
2023
Q3 		$3.69M Sell
54,199
-2,451
-4% -$208K 0.01% 877
2023
Q2 		$5.35M Sell
56,650
-8,895
-14% -$694K 0.01% 693
2023
Q1 		$4.45M Sell
65,545
-195,556
-75% -$12.6M 0.01% 802
2022
Q4 		$13M Sell
261,101
-41,044
-14% -$1.68M 0.03% 465
2022
Q3 		$9.88M Sell
302,145
-21,243
-7% -$876K 0.03% 508
2022
Q2 		$12.7M Buy
323,388
+198,107
+158% +$10.6M 0.03% 472
2022
Q1 		$9.27M Sell
125,281
-9,850
-7% -$720K 0.02% 604
2021
Q4 		$10.5M Sell
135,131
-1,072
-0.8% -$94.6K 0.02% 578
2021
Q3 		$13.1M Buy
136,203
+10,495
+8% +$1.11M 0.03% 498
2021
Q2 		$15.6M Buy
125,708
+23,220
+23% +$2.77M 0.04% 471
2021
Q1 		$13.4M Buy
102,488
+19,352
+23% +$2.65M 0.03% 499
2020
Q4 		$11M Buy
83,136
+9,150
+12% +$1.11M 0.02% 588
2020
Q3 		$7.55M Buy
73,986
+11,536
+18% +$996K 0.02% 612
2020
Q2 		$5.4M Buy
62,450
+2,743
+5% +$219K 0.01% 662
2020
Q1 		$3.48M Buy
59,707
+426
+0.7% +$34.6K 0.01% 737
2019
Q4 		$5.44M Buy
+59,281
New +$5.21M 0.01% 699
2019
Q3 		– Sell
-30,314
Closed -$3.58M – 1488
2019
Q2 		$3.58M Buy
30,314
+13,489
+80% +$1.36M 0.01% 873
2019
Q1 		$1.45M Buy
16,825
+1,921
+13% +$164K ﹤0.01% 1233
2018
Q4 		$908K Buy
14,904
+1,779
+14% +$122K ﹤0.01% 1436
2018
Q3 		$1.04M Hold
13,125
– – ﹤0.01% 1515
2018
Q2 		$785K Hold
13,125
– – ﹤0.01% 1620
2018
Q1 		$530K Sell
13,125
-2,263
-15% -$110K ﹤0.01% 1720
2017
Q4 		$807K Buy
15,388
+2,084
+16% +$111K ﹤0.01% 1595
2017
Q3 		$616K Buy
13,304
+2,543
+24% +$102K ﹤0.01% 1667
2017
Q2 		$380K Hold
10,761
– – ﹤0.01% 1764
2017
Q1 		$254K Hold
10,761
– – ﹤0.01% 1866
2016
Q4 		$144K Hold
10,761
– – ﹤0.01% 2002
2016
Q3 		$199K Hold
10,761
– – ﹤0.01% 1909
2016
Q2 		$131K Hold
10,761
– – ﹤0.01% 2008
2016
Q1 		$72K Hold
10,761
– – ﹤0.01% 1972
2015
Q4 		$99K Hold
10,761
– – ﹤0.01% 1766
2015
Q3 		$194K Sell
10,761
-163,706
-94% -$3.76M ﹤0.01% 1268
2015
Q2 		$5.18M Sell
174,467
-47,100
-21% -$1.18M 0.02% 612
2015
Q1 		$4.87M Sell
221,567
-1,600
-0.7% -$40.6K 0.02% 631
2014
Q4 		$6.13M Buy
223,167
+19,029
+9% +$463K 0.02% 554
2014
Q3 		$3.96M Hold
204,138
– – 0.01% 658
2014
Q2 		$3.47M Hold
204,138
– – 0.01% 689
2014
Q1 		$2.88M Sell
204,138
-18,194
-8% -$246K 0.01% 730
2013
Q4 		$2.6M Sell
222,332
-7,300
-3% -$83.7K 0.01% 728
2013
Q3 		$2.71M Buy
229,632
+3,132
+1% +$40.2K 0.01% 683
2013
Q2 		$3.15M Buy
+226,500
New +$2.46M 0.02% 358

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Canada Life's EXAS Position: Q1 2026 in Review

Canada Life sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,341 shares — an estimated $2.27M sold.

Canada Life first reported a position in EXAS in Q2 2013 and held it in 50 quarters. The position peaked at $15.6M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Canada Life reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Canada Life sold 22,341 Exact Sciences shares in Q1 2026, an estimated $2.27M.
  • Canada Life first reported a position in Exact Sciences in Q2 2013 and held it in 50 quarters.
  • Canada Life's Exact Sciences position peaked at $15.6M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.